优先提供者组织（PPO）是一种竞争力量还是反托拉斯风险？
Are PPOs a competitive force or antitrust risk?
作者信息
Enders R J
出版信息
Healthc Financ Manage. 1986 May;40(5):52-60.
PMID:10276171
Abstract
The formation of PPOs is being encouraged as a procompetitive force in the healthcare marketplace. However, this encouragement is being cautioned with the prospect of possible antitrust violations. Although very few antitrust lawsuits have been filed, the risk still remains. PPOs are certainly a significant factor in today's healthcare field and eventually, more antitrust challenges will develop.
摘要
优先提供者组织（PPO）的形成作为医疗保健市场中的一种促进竞争力量而受到鼓励。然而，这种鼓励伴随着可能违反反垄断法的风险而受到告诫。尽管很少有反垄断诉讼被提起，但风险仍然存在。PPO在当今的医疗保健领域无疑是一个重要因素，最终，将会出现更多的反垄断挑战。
相似文献
1
Are PPOs a competitive force or antitrust risk?
Healthc Financ Manage. 1986 May;40(5):52-60.
2
Can provider antitrust suits against payers be successful?
Healthc Financ Manage. 1986 Jun;40(6):72-80.
3
Perspectives. PPOs face antitrust problems.
Wash Rep Med Health. 1984 Nov 5;38(44):suppl 4p.
4
Hospital-physician collaboration and competition: the antitrust connection.
Healthc Financ Manage. 1986 Apr;40(4):60-8.
5
Preferred provider organizations, price-fixing and Section 1 of the Sherman Act.
Health Matrix. 1987 Fall;5(3):9-16.
6
The development of preferred provider organizations and its antitrust implications.
J Med Pract Manage. 1985 Oct;1(2):130-5.
7
Evaluating antitrust risk in joint provider negotiations with payors.
Med Staff Couns. 1992 Winter;6(1):41-7.
8
Monopolies, Maricopa, and marketing: a case study.
Hosp Health Serv Adm. 1986 Jul-Aug;31(4):34-44.
9
Understanding antitrust: focus on the relevant market.
Healthc Financ Manage. 1986 Feb;40(2):25-32.
10
Preferred provider organizations and antitrust policy: some recent issues.
Health Matrix. 1986 Summer;4(2):22-5.
Zotero 插件